Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lannett
Trevose, Pennsylvania, United Stateslannett.com ↗
- Ownership
- Public · LCI
- Employees
- ~1100
- Development stage
- Other
01
Overview
Lannett has over 100 marketed generic pharmaceutical products in the US, including newly approved products such as mycophenolate mofetil for oral suspension and a portfolio of both high-value and traditional generics in solid, liquid, and semi-solid forms, with additional ANDAs pending or in late-stage development[1][2][4][9].
- Therapeutic areas
- ImmunologyRheumatologyPsychiatryInfectious DiseasesCardiovascularOtherNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Jerome Stevens Pharmaceuticals (levothyroxine distribution, now expired)[2]Endo International (acquisition of product portfolio)[6][8]Societal CDMO Gainesville LLC (distribution agreement for verapamil; recently terminated)[2]
Beyond the preview
Go deeper on Lannett.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lannett.